Summary
The Vall d’Hebron Institute of Oncology (VHIO) is offering a fully funded Predoctoral Position for a PhD student under the leadership of Dr. Pere Barba. This position focuses on advancing knowledge in CAR T-cell therapies and is set in a multidisciplinary and collaborative research environment.
Fully Funded PhD Scholarship in CAR T-Cell Therapy Research at VHIO, Spain
Designation
Predoctoral Position (PhD Student) – CAIMI Synergy Grant
| Key Information | Details |
|---|---|
| Reference | 2026-038-01 |
| Application Deadline | June 26, 2026 |
| Number of Vacancies | 1 (Fully funded PhD position for 3 years) |
Research Area
- Immunology
- Cancer Research
- Cellular Therapies
- Genomics and Cell Engineering
Location
Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
Eligibility/Qualification
Essential:
- Bachelor’s/Master’s degree in Biomedicine, Biotechnology, Biochemistry, Immunology, Molecular Biology, Bioengineering, or a related discipline.
- Strong interest in immunology, cancer research, and cellular therapies.
- Excellent communication skills in English (both written and spoken).
- Ability to work independently and within a multidisciplinary team.
Desirable:
- Research experience in immunology, molecular biology, cell culture, genomics.
- Experience with flow cytometry, CRISPR technologies, primary cell culture, and T-cell biology.
- Basic programming skills in R or Python.
- Experience with NGS data analysis or bioinformatics.
Job Description
The successful candidate will engage in a translational project to investigate why certain CAR T-cell therapies yield durable responses while others do not. The position will involve applying advanced technologies such as:
- Flow cytometry-based cell sorting
- Deep whole-exome sequencing
- CRISPR-based genome engineering
- Functional characterization of engineered T cells.
The candidate will be part of a collaborative environment, working alongside clinicians, immunologists, computational biologists, and bioinformaticians.
How to Apply
Interested candidates should apply through the VHIO website by submitting their CV, cover letter, and other required documents, referencing the position code 2026-038-01.
Last Date to Apply
June 26, 2026
This opportunity presents a unique chance to contribute to innovative cancer therapies while developing professional skills in a premier research environment.
